跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 290,811 条关于
“heparan-sulfate non-reducing end”
全部
290,811
临床试验
262,994
药物
2,481
机构
865
资讯
24,471
11个月前
Spruce Biosciences' TA-ERT Receives FDA Breakthrough Therapy Designation for Ultra-Rare Sanfilippo Syndrome Type B
去年
Spruce Biosciences Reports Breakthrough Long-Term Data for TA-ERT in Rare Sanfilippo Syndrome Type B
7个月前
Spruce Biosciences Reports Six-Year Data Showing Tralesinidase Alfa Preserves Cognitive Function in Sanfilippo Syndrome Type B
去年
Spruce Biosciences Acquires Tralesinidase Alfa for Sanfilippo Syndrome Type B Treatment with BLA Submission Planned for 2026
去年
Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A
去年
GC Biopharma and Novel Pharma Initiate Phase I Trial of GC1130A for Sanfilippo Syndrome Type A
2年前
JCR Pharmaceuticals' JR-441 Receives Clearance for Phase I MPS IIIA Trial in Japan
11个月前
JR-446 Receives Japanese Orphan Drug Designation for Rare Sanfilippo Syndrome Type B
去年
Ultragenyx's UX111 Gene Therapy for Sanfilippo Syndrome Type A Receives FDA Priority Review
去年
Metformin Shows Promise in Reducing Non-Melanoma Skin Cancer Risk, Study Finds
第 1 页，共 2448 页
上一页
下一页
